期刊文献+

米碎花药效微小核糖核酸的鉴定及其靶基因功能分析 被引量:4

Identification of MicroRNAs from Eurya chinensis and function analysis on their target genes
原文传递
导出
摘要 目的筛选米碎花Eurya chinensis茎叶的微小核糖核酸(Micro RNAs,mi RNAs)类药效物质及其靶基因功能分析。方法采用高通量测序法,测定米碎花、正常小鼠和喂食米碎花匀浆液小鼠肝组织及血浆中mi RNAs的表达丰度,并与Gene Bank上的植物mi RNAs数据库比对,结合实时荧光定量PCR(RTFQ-PCR)验证,鉴定吸收进入体内的米碎花mi RNAs。以人类m RNA为靶标,采用Target Scan与Mi Randa预测米碎花mi RNAs的靶基因,并通过基因功能聚类(GO)与KEGG分析靶基因的相关功能。结果共鉴定出5个米碎花mi RNAs可吸收进入体内,其主要在生化过程、细胞成分和分子功能3大区域发挥作用,并影响肿瘤、代谢、炎症等相关信号通路。结论 mi RNAs可能是一类新型的中药药效物质。 Objective To investigate the pharmacodynamic Micro RNAs(miRNAs) in Eurya chinensis and the functions of their target genes. Methods The mi RNA profiles of E. chinensis in liver and plasma of normal mice and E. chinensis extract-treated mice were detected using high-flux sequencing, and then the miRNAs which took into the organism were validated by RTFQ-PCR using plant mi RNA database in Gene Bank. Human mRNA database as target was used to predict the target genes of miRNAs by Target Scan and Mi Randa analysis, while the target gene functions were considered by GO and KEGG analyses. Results Five pharmacodynamic micro RNAs were identified and took part in biological processes, cellular components, and molecular functions, which affected tumor, metabolism, and inflammation-related signal pathways. Conclusion The miRNAs might act as new pharmacodynamic materials of Chinese materia medica.
出处 《中草药》 CAS CSCD 北大核心 2015年第1期80-85,共6页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金资助项目(81202977 81473339) 浙江省卫生高层次创新人才项目
关键词 药效物质 米碎花 微小核糖核酸 MAPK信号通路 高通量测序 pharmacodynamic material Eurya chinensis R.Brown micro RNAs MAPK signal pashway high-flux sequencing
  • 相关文献

参考文献6

二级参考文献122

共引文献55

同被引文献71

  • 1郑文岭,马文丽.消化道基因治疗:中医药治疗机制的探讨[J].科技导报,1994,12(12):8-11. 被引量:18
  • 2Calin GA, Sevignani C, Dumitru CD,et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J].Proc Natl Acad Sci U S A, 2004,101 (9) : 2999-3004.
  • 3Komatsu S, Ichikawa D,TaKeshita H,et d.Circulating mi- croRNAs in plasma of patients with oesophageal squamous cell carcinoma[J].Br J Cancer, 2011,105 ( 1 ) : 104-111.
  • 4Kurashige J,Kamohara H,Watanabe M,et d.Serum mi- croRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma[J].J Surg Oncol, 2012,106 (2) : 188-192.
  • 5Chen ZL,Zhao XH,Wang JW,et al.microRNA-92a pro- motes lymph node metastasis of human esophageal squa- mous cell carcinoma via Ecadherin[J].J Biol Chem,2011, 286(12) : 10725-10734.
  • 6Katada T,Ishiguro H,Kuwabara Y,et d.MicroRNA ex- pression profile in undifferentiated gastric cancer[J].In~ J Oncol, 2009,34 (2) : 537-542.
  • 7Liu T,Tang H,Lang Y,et d.MicroRNA-27a functions as an oneogene in gastric adenocarcinoma by targeting pro- hibitin[J].Cancer Lett, 2009,273 (2): 233-242.
  • 8Bandres E,Bitarte N,Arias F,et al.microRNA-451 regu- lates maerophage migration inhibitory factor production and proliferation of gastrointestinal cancer eells[J~Clin Can- cer Res, 2009,15 (7) : 2281-2290.
  • 9Jiang Z, Guo J, Xiao B, et al.Increased expression of miR- 421 in human gastric carcinoma and its clinical assoeia- tion[J].J Gastroenterol, 2010,45 ( 1 ) : 17-23.
  • 10Hutvagner G,Zamore PD.A microRNA in a multiple - turnover RNAi enzyme complex [J].Science, 2002,297(5587):2056-2060.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部